Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Abiomed Inc. |
---|---|
Information provided by: | Abiomed Inc. |
ClinicalTrials.gov Identifier: | NCT00669357 |
Abiocor is a post market approval study for an Implantable Replacement Heart
Condition | Intervention |
---|---|
Severe Biventricular End Stage Heart Disease |
Device: Abiocor Implantable Replacement Heart |
Study Type: | Expanded Access |
Official Title: | AbioCor Implantable Replacement Heart |
Ages Eligible for Study: | up to 75 Years |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contact: Robert T.V. Kung, PhD | 978-646-1400 | kungr@abiomed.com |
United States, Indiana | |
St Vincent Hospital | |
Indianapolis, Indiana, United States | |
United States, Maryland | |
John Hopkins University Hospital | |
Baltimore, Maryland, United States | |
United States, New Jersey | |
Robert Wood Johnson | |
New Brunswick, New Jersey, United States | |
United States, Texas | |
St Lukes @ Texas Heart Institute | |
Houston, Texas, United States |
Study Director: | Robert T.V. Kung, PhD | Abiomed Inc. |
Responsible Party: | Abiomed Inc ( Robert Kung ) |
Study ID Numbers: | H040006 |
Study First Received: | April 25, 2008 |
Last Updated: | April 29, 2008 |
ClinicalTrials.gov Identifier: | NCT00669357 |
Health Authority: | United States: Institutional Review Board |
End stage heart disease |
Heart Diseases |
Cardiovascular Diseases |